Late relapse of stage I seminoma following single-agent carboplatin

被引:2
|
作者
Raj, S. [1 ]
Williams, M. V. [1 ]
Dixon, A. K. [1 ]
Robson, J. [1 ]
Mazhar, D. [1 ]
机构
[1] Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England
关键词
stage I seminoma; carboplatin;
D O I
10.1159/000136798
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We present a case report of a patient who received adjuvant carboplatin for stage 1 seminoma and relapsed with abdominal lymph node metastasis at 48 months. In recent years, many oncologists have offered a single cycle of adjuvant carboplatin AUC7 as adjuvant treatment for stage 1 seminoma. The available data show a non-inferior relapse-free survival at 3 years compared with para-aortic radiotherapy. The rate of relapse beyond this point has not been reported. Patients with stage 1 seminoma represent a group of patients with excellent outcomes, and treatment options must also consider the late effects of treatment, of which there are increasing data of mortality for those treated with radiotherapy. Patients who opt for surveillance have a greater than 80% chance of remaining relapse free at 5 years, but those on surveillance require more CT examinations for follow-up. For those treated with single-agent carboplatin, our case report highlights that late relapse can occur, and we suggest that CT surveillance beyond 2 years is required given the lack of mature data on late relapse. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:419 / 421
页数:3
相关论文
共 50 条
  • [41] Controversies in the management of stage I seminoma: adjuvant carboplatin revisited
    J. Aparicio
    J. Terrasa
    Clinical and Translational Oncology, 2019, 21 : 246 - 247
  • [42] Is carboplatin as effective as radiotherapy for the adjuvant treatment of stage I seminoma?
    Carsten Bokemeyer
    Nature Clinical Practice Urology, 2005, 2 : 586 - 587
  • [43] Is carboplatin as effective as radiotherapy for the adjuvant treatment of stage I seminoma?
    Bokemeyer, C
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (12): : 586 - 587
  • [44] Patterns of relapse following radiotherapy for Stage I seminoma of the testis: Implications for the follow-up
    Livsey, JE
    Taylor, B
    Mobarek, N
    Cooper, RA
    Carrington, B
    Logue, JP
    CLINICAL ONCOLOGY, 2001, 13 (04) : 296 - 300
  • [45] Probable cutaneous hypersensitivity to carboplatin single-agent chemotherapy in a dog
    Lanore, D.
    Sayag, D.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2010, 51 (12) : 654 - 656
  • [46] TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH SINGLE-AGENT CARBOPLATIN
    BURKE, TW
    MUNKARAH, A
    KAVANAGH, JJ
    MORRIS, M
    LEVENBACK, C
    TORNOS, C
    GERSHENSON, DM
    GYNECOLOGIC ONCOLOGY, 1993, 51 (03) : 397 - 400
  • [47] SINGLE-AGENT CARBOPLATINUM FOR ADVANCED SEMINOMA - A PHASE-II STUDY
    SCHMOLL, HJ
    HARSTRICK, A
    BOKEMEYER, C
    DIECKMANN, KP
    CLEMM, C
    BERDEL, WE
    SOUCHON, R
    SCHOBER, C
    WILKE, H
    POLIWODA, H
    CANCER, 1993, 72 (01) : 237 - 243
  • [48] Single-agent carboplatin chemotherapy in patients with advanced breast cancer
    Gunter, HH
    Wander, HE
    Nagel, GA
    Lelle, RJ
    Glaubitz, M
    WedekingSchohl, H
    Luck, HJ
    Kuhnle, H
    ONKOLOGIE, 1995, 18 (06): : 556 - 560
  • [49] Prognostic factors for relapse in stage I seminoma managed by surveillance or adjuvant carboplatin: A multivariate analysis on 588 cases.
    Aparicio, J.
    Garcia-Puche, J.
    Lomas, M.
    Carabantes, F.
    Vazquez, S.
    Crespo, C.
    Climent, M.
    Murias, A.
    Oltra, A.
    Barrajon, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 229S - 229S